| Year |
Citation |
Score |
| 2023 |
Son KH, Aldonza MBD, Nam AR, Lee KH, Lee JW, Shin KJ, Kang K, Cho JY. Integrative mapping of the dog epigenome: Reference annotation for comparative intertissue and cross-species studies. Science Advances. 9: eade3399. PMID 37406108 DOI: 10.1126/sciadv.ade3399 |
0.581 |
|
| 2023 |
Aldonza MBD, Cha J, Yong I, Ku J, Sinitcyn P, Lee D, Cho RE, Delos Reyes RD, Kim D, Kim S, Kang M, Ku Y, Park G, Sung HJ, Ryu HS, et al. Multi-targeted therapy resistance via drug-induced secretome fucosylation. Elife. 12. PMID 36961502 DOI: 10.7554/eLife.75191 |
0.685 |
|
| 2021 |
Shin SB, Kim DH, Kim DE, Aldonza MBD, Kim Y, Yim H. Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers. 13. PMID 34503223 DOI: 10.3390/cancers13174413 |
0.695 |
|
| 2021 |
Aldonza MBD, Reyes RDD, Kim YS, Ku J, Barsallo AM, Hong JY, Lee SK, Ryu HS, Park Y, Cho JY, Kim Y. Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass Scientific Reports. 11: 8016. PMID 33850249 DOI: 10.1038/s41598-021-87599-9 |
0.577 |
|
| 2021 |
Aldonza MBD, Reyes RDD, Kim YS, Ku J, Barsallo AM, Hong JY, Lee SK, Ryu HS, Park Y, Cho JY, Kim Y. Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. Scientific Reports. 11: 8016. PMID 33850249 DOI: 10.1038/s41598-021-87599-9 |
0.679 |
|
| 2021 |
Aldonza MB, Cha J, Yong I, Lee D, Ku J, Lee D, Sinitcyn P, Cho RE, Delos Reyes RD, Kim D, Sung HJ, Kim S, Kang M, Ku Y, Park G, et al. Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation Biorxiv. DOI: 10.1101/2021.04.21.440719 |
0.403 |
|
| 2020 |
Aldonza MBD, Ku J, Hong JY, Kim D, Yu SJ, Lee MS, Prayogo MC, Tan S, Kim D, Han J, Lee SK, Im SG, Ryu HS, Kim Y. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Science Advances. 6: eaav7416. PMID 32083171 DOI: 10.1126/Sciadv.Aav7416 |
0.731 |
|
| 2017 |
Aldonza MBD, Son YS, Sung HJ, Ahn JM, Choi YJ, Kim YI, Cho S, Cho JY. Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells. Oncotarget. PMID 28467805 DOI: 10.18632/oncotarget.17069 |
0.667 |
|
| 2017 |
Aldonza MB, Hong JY, Lee SK. Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. Experimental & Molecular Medicine. 49: e286. PMID 28104912 DOI: 10.1038/emm.2016.131 |
0.601 |
|
| 2016 |
Aldonza MB, Hong JY, Alinsug MV, Song J, Lee SK. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. Oncotarget. PMID 27284014 DOI: 10.18632/oncotarget.9118 |
0.608 |
|
| 2015 |
Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK. Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Plos One. 10: e0133922. PMID 26196696 DOI: 10.1371/journal.pone.0133922 |
0.571 |
|
| 2015 |
Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Plos One. 10: e0127841. PMID 26098947 DOI: 10.1371/journal.pone.0127841 |
0.526 |
|
| 2015 |
Na SS, Aldonza MB, Sung HJ, Kim YI, Son YS, Cho S, Cho JY. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression. Biochimica Et Biophysica Acta. 1854: 668-76. PMID 25463045 DOI: 10.1016/j.bbapap.2014.11.002 |
0.655 |
|
| Show low-probability matches. |